Screener
Ionis Pharmaceuticals IONS PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Inventories | 50,833 | 10,048 |
| Other current assets | 327,011 | 237,092 |
| Total current assets | 2,491,274 | 2,990,635 |
| Property, plant and equipment, net | 155,131 | 123,048 |
| Right-of-use assets | 231,560 | 238,549 |
| Deposits and other assets | 116,536 | 171,604 |
| Total assets | $$2,994,501 | 3,523,836 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's PP&E (net)?
- Ionis Pharmaceuticals (IONS) reported PP&E (net) of $155.13M in Q2 2026.
- How has Ionis Pharmaceuticals's PP&E (net) changed year-over-year?
- Ionis Pharmaceuticals's PP&E (net) increased by 38.6% year-over-year, from $111.95M to $155.13M.
- What is the long-term trend for Ionis Pharmaceuticals's PP&E (net)?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's PP&E (net) has grown at a -7.4% compound annual growth rate (CAGR), from $181.08M to $123.05M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Ionis Pharmaceuticals's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude